The BMTF aims to provide an environment in which the existing research expertise from partners and collaborators will come together to create critical mass in collaborative multidisciplinary research teams, to develop new materials for devices, diagnostics, delivery technologies, imaging agents and the assessment of these materials through new, non-invasive, in situ imaging techniques.
Medical Bionics is a multi-disciplinary field of research combining bio(logy) and (electro)nics in order to develop implantable devices designed to provide sensory or motor function following damage to nerve or muscle tissue. The cochlear implant (bionic ear) is the most sophisticated and successful medical bionic device in use today The Bionics Institute Preclinical Trials for Medical Devices provides a service for the testing of medical devices for safety and efficacy.
Two biological isolator facilities have been established to facilitate clinical development of human cell-based therapies. Established under the auspices of the Victorian Consortium for Cell-based Therapies (VCCT), the isolators provide a complete barrier from environmental and operator-borne contamination and are therefore ideally suited for aseptic processing.
The Be Active Sleep and Eat (BASE) state-of-the-art research facility, at the world renowned Monash University, is dedicated to advance the science of nutrition, sleep and activity and maximize healthy outcomes for all Australians. The facility was officially launched on the 1st October 2013 to encapsulate research and education in the areas of nutrition (Department of Nutrition & Dietetics), sleep (School of Psychological Sciences) and exercise and activity (Department of Physiology and Department of Physiotherapy) within the Faculty of Medicine, Nursing and Health Sciences . Through a multidisciplinary approach, the team of accredited academics and professionals are pioneering the integration of nutrition, sleep and exercise physiology from research into practice. A wide range of products and services are available to suit individuals , groups , and companies the to assist in the enhancement of health across the lifespan.
Melbourne Translational Genomics Platform makes genome analysis capabilities available to researchers of the University and precinct, accelerates adoption of these technologies in clinical practice, and supports research and clinical discovery. It is an evolving resource of cutting-edge technology and knowledge accessible to researchers and clinicians of all disciplines, and aims to foster cross-pollination of capabilities and experience between the University, clinical institutions and industry
With extensive international experience, the biostatistics group at the Epworth has diverse expertise in all areas of statistics (incl, biostatistics, clinical epidemiology, health economics, clinical trials design) and have worked across diverse range of environments, including academic, international pharmaceutical companies and government.